Embolization Coil Market Highlights

• Global embolization coil market revenue is poised to garner USD 3,273.4 million by 2032 with a CAGR of 5.9% from 2024 to 2032
• North America embolization coil market value occupied around USD 789.8 million in 2023
• Asia-Pacific embolization coil market growth will record a CAGR of more than 6.5% from 2024 to 2032
• Among end-user, the hospitals sub-segment generated more than USD 750.3 million revenue in 2023
• Based on application, the neurology sub-segment generated around 33% market share in 2023
• Rising demand for embolization coils in oncology treatments is a popular embolization coil market trend that fuels the industry demand

The global prevalence of cerebrovascular illnesses such as cerebral aneurysms & arteriovenous malformations, as well as the rising adoption of minimally invasive procedures, are the key factors driving the embolization coil industry growth. Furthermore, the introduction of new, more advanced embolization coils and associated technologies is expected to encourage the growth of the embolization coil industry value.

Embolization coils are thin, wire-like tools that are inserted by a catheter into a blood vessel and deployed within an aneurysm or other vascular abnormality. The coils prevent the blood flow into the aneurysm or abnormality from rupturing and triggering other problems. They are most typically used to treat cerebrovascular conditions such arteriovenous malformations (AVMs), cerebral aneurysms, and arteriovenous fistulas.

Global Embolization Coil Market Dynamics

Market Drivers

• Increased prevalence of neurological disorders
• Technological advancements in product development
• Rising adoption of minimally invasive procedures
• Growing occurrence of aneurysms

Market Restraints

• High cost of treatment
• Stringent regulatory framework
• Limited availability of skilled professionals

Market Opportunities

• Introduction of new products by leading companies
• Increasing spending on healthcare
• Expanding medical tourism in emerging economies

Embolization Coil Market Report Coverage

Embolization Coil Market Insights

The embolization coil refers to an endovascular intervention technique used for the treatment of intracranial ruptured or unruptured aneurysms and other disorders. The swift development of embolization techniques has permitted endovascular treatment to be applied to more complex aneurysms that were initially impossible to treat via traditional endovascular techniques. However, it is still difficult to apply this endovascular treatment method to a small branch-incorporated aneurysm. The paradigm shift from clipping to coiling and gradually towards non-coiling techniques has opened doors of opportunities in the global embolization coil market. Rising demand for minimally invasive surgery is the major factor driving the global market growth.

The growing use of minimally invasive procedures for the treatment of neurological illnesses is expected to stimulate demand for embolization coils and other medical equipment utilized in these operations. Minimally invasive techniques provide various benefits over traditional surgical intervention, such as faster recovery & fewer problems. Global healthcare expenditures are predicted to rise in the next years, owing to factors such as increasing earnings and an increased prevalence of chronic illnesses. As even more individuals have access to and are able to afford healthcare services, the market for medical devices, notably embolization coils, is expected to rise.

Embolization Coil Market Segmentation

The worldwide market for embolization coil is split based on type, material, application, end-user, and geography.

Embolization Coil Types

• Pushable Coils
• Detachable Coils

According to an embolization coil industry analysis, the detachable coil segment held the largest market share in 2024. Detachable embolization coils are primarily constructed of platinum, nickel-titanium, as well as stainless steel, and exist in a range of forms and sizes to accommodate various therapeutic applications. Moreover,  factors such as the rising prevalence of neurological illnesses, technological developments in these segments, the increased uptake of minimally invasive procedures, and rising healthcare costs, the industry for detachable embolization coils is anticipated to expand in the upcoming years.

Embolization Coil Materials

• Platinum
• Platinum & Hydrogel
• Platinum Tungsten Alloy

In terms of material, platinum is a frequently used material in the embolization coils industry in 2023. Platinum is a strong, biocompatible material that is corrosion-resistant and has a modest profile when used to repair an aneurysm or other vascular malformation. It is a popular material for embolization coil manufacture because to its high radiopacity, which allows it to be easily seen under fluoroscopy. Platinum's endurance and biocompatibility may make it an enticing choice for certain medicinal applications, perhaps boosting future growth.

Embolization Coil Applications

• Neurology
• Oncology
• Urology
• Cardiology
• Peripheral Vascular Disease
• Others

According to the embolization coil market forecast, the neurology application category is predicted to grow significantly in the market over the next few years. In neurology, embolization coils are often used to treat cerebrovascular disorders such as aneurysms, arteriovenous malformations (AVMs), & arteriovenous fistulas (AVFs). These conditions can develop in brain blood vessels and put them in danger of rupturing, which can lead to significant problems like stroke or brain damage.

Embolization Coil End-users

• Hospitals
• Ambulatory Center
• Cardio Center
• Others

In terms of end-users, the hospital sector leads the embolization coil market in 2023. Hospitals are well-equipped to manage the treatment and diagnosis of cerebrovascular illnesses, and they have the hospital professionals, technology, and facilities to execute treatments such as embolization with embolization coils. Furthermore, hospitals are usually able to provide a better degree of support and assistance to patients undergoing these treatments, such as specialist care from neurologists as well as other medical professionals.

Embolization Coil Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Embolization Coil Market Regional Analysis

In terms of embolization coil market analysis, geographically, North America is the leading region of the market in 2023. Factors such as the rising prevalence of cerebrovascular illnesses, increasing healthcare costs, and growing demand for advanced medical equipment are driving market growth. The widespread use of embolization coils for treating cerebrovascular conditions, coupled with rising earnings and healthcare spending, is further boosting the North American market. The region's focus on improving patient outcomes with advanced medical technologies also supports market expansion.

Asia-Pacific is rising as the fastest-growing area during embolization coil market forecast period, owing to the rise in neurological illnesses and quick expansion of healthcare infrastructure. Countries such as China, India, and Japan are seeing an increase in the use of modern medical technologies, notably for treating illnesses like aneurysms. Government measures to improve healthcare accessible, combined with an older population and increased awareness of early detection, are driving the embolization coil market in this region. Furthermore, the growing presence of leading market players in Asia-Pacific is driving growth.

Embolization Coil Market Players

Some of the top embolization coil companies offered in our report includes Abbott Laboratories, Terumo Corporation, Boston Scientific, Stryker Corporation, DePuy Synthes, Medtronic, St. Jude Medical, Sirtex, Cook Medical, and Cordis Corporation.